SCHEMBL15479129

SCHEMBL15479129

Cc1ccc(C(=O)Nc2csc(-c3ccc(Cl)cc3Cl)c2C(=O)O)c(Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.60
PPARA Q07869 1/20 0.60
RAB9A P51151 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
NPC1 O15118 1/20 0.56
ANO1 Q5XXA6 3/20 0.52
TP53 P04637 2/20 0.52
MAPT P10636 1/20 0.51
GPR35 Q9HC97 2/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.43
KCNMA1 Q12791 1/20 0.42
KDM4E B2RXH2 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
FLT1 P17948 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12831290 0.93 ANO1 (0.58) PPARGPPARARAB9ASMN1; SMN2NPC1
SCHEMBL12756883 0.87 MAPT (0.48) PPARGPPARARAB9ASMN1; SMN2NPC1
SCHEMBL12756890 0.87 PPARG (0.56) PPARGPPARARAB9ASMN1; SMN2NPC1
SCHEMBL1490743 0.84 KCNK3 (0.50) PPARGPPARANPC1TP53MAPT
SCHEMBL1490227 0.82 MEN1 (0.49) RAB9ASMN1; SMN2NPC1ANO1MAPT
SCHEMBL12756881 0.82 PPARG (0.49) PPARGPPARARAB9ASMN1; SMN2NPC1
SCHEMBL13819654 0.82 ANO1 (0.71) PPARGPPARARAB9ASMN1; SMN2NPC1
SCHEMBL12756888 0.81 NPC1 (0.45) RAB9ASMN1; SMN2NPC1ANO1TP53
SCHEMBL12831284 0.81 ANO1 (0.56) PPARGPPARARAB9ASMN1; SMN2NPC1
SCHEMBL12831286 0.81 MAPT (0.45) RAB9ANPC1ANO1MAPTGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 PPARG 1551/4885PPARA 2210/4885RAB9A 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.